SCHEMBL3522522

SCHEMBL3522522

O=C(C1=C2c3ccccc3Cc3ccc(Cl)cc3N2CCC1)C(Cl)(Cl)Cl

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PGR P06401 1/20 0.40
DRD2 P14416 4/20 0.39
DRD4 P21917 4/20 0.39
HSD17B3 P37058 1/20 0.37
RXRA P19793 1/20 0.37
RXRB P28702 1/20 0.37
RXRG P48443 1/20 0.37
MAPT P10636 4/20 0.35
NPSR1 Q6W5P4 2/20 0.35
LMNA P02545 1/20 0.35
TDP1 Q9NUW8 1/20 0.35
NOTUM Q6P988 1/20 0.35
CNR1 P21554 1/20 0.35
SRD5A2 P31213 1/20 0.34
KDM4E B2RXH2 1/20 0.34
MEN1 O00255 1/20 0.34
ALDH1A1 P00352 1/20 0.34
GAA P10253 1/20 0.34
ALOX12 P18054 1/20 0.34
KMT2A Q03164 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3521856 0.84 DRD2 (0.41) PGRDRD2DRD4HSD17B3RXRA
SCHEMBL3518811 0.81 PGR (0.41) PGRDRD2DRD4MAPTTDP1
SCHEMBL3522109 0.80 BCHE (0.41) PGRMAPTLMNAMEN1ALDH1A1
SCHEMBL3522498 0.69 DRD2 (0.49) PGRDRD2DRD4HSD17B3MAPT
SCHEMBL3522804 0.65 PGR (0.42) PGRDRD2DRD4MAPTTDP1
SCHEMBL3520212 0.65 TP53 (0.46) MAPTLMNAMEN1ALDH1A1KMT2A
SCHEMBL1921628 0.61 KDM4E (0.59) DRD2DRD4MAPTLMNACNR1
SCHEMBL3785566 0.61 ITGA1 (0.54) DRD2DRD4MAPTLMNACNR1
SCHEMBL5022723 0.59 PGR (0.64) PGRDRD2DRD4HSD17B3NOTUM
SCHEMBL3522292 0.59 PGR (0.64) PGRDRD2DRD4HSD17B3NOTUM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7737136-B2 Non-steroidal progesterone receptor modulators N.V. ORGANON (NL) 2010-06-15 US disclosed
EP-1495030-B1 NON-STEROIDAL PROGESTERONE RECEPTOR MODULATORS ORGANON NV (NL) 2008-08-13 EP disclosed
US-20050171087-A1 Non-steroidal progesterone receptor modulators MERCK SHARP & DOHME B.V. (NL) 2005-08-04 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050171087-A1 Non-steroidal progesterone receptor modulators PGR, PGRMC1, PGRMC2 PGR 1/4885DRD2 2299/4885DRD4 2339/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.